Anna Sundholm
Affiliated to Research
E-mail: anna.sundholm@ki.se
Visiting address: Solnavägen 9, 17165 Solna
Postal address: C4 Neurovetenskap, C4 Forskning Carmine Belin, 171 77 Stockholm
Articles
- Article: HEADACHE. 2025;65(8):1294-1307Jennysdotter Olofsgard F; Ran C; Spulber S; Steinberg A; Sjostrand C; Waldenlind E; Lantz M; Sundholm A; Soderstrom M; Dahlgren A; Belin AC
- Article: PATHOGENS. 2023;12(3):476Sundholm A; Gustafsson R; Karrenbauer V
- Article: CEPHALALGIA. 2021;41(14):1427-1436Sundholm A; Burkill S; Waldenlind E; Bahmanyar S; Nilsson Remahl AIM
- Journal article: CEPHALALGIA REPORTS. 2021;4:25158163211020447Helmerson B; Sundholm A; Hedborg K; Waldenlind E; Kierkegaard M; Remahl AIMN
- Article: CEPHALALGIA. 2020;40(10):1084-1094Sundholm A; Burkill S; Waldenlind E; Bahmanyar S; Nilsson Remahl AIM
- Article: LAKARTIDNINGEN. 2020;117:FTS7Sundholm A; Steinberg A
- Article: ACTA NEUROLOGICA SCANDINAVICA. 2018;137(3):341-346Sundholm A; Burkill S; Bahmanyar S; Remahl AIMN
- Article: ACTA NEUROLOGICA SCANDINAVICA. 2017;136(5):427-433Sundholm A; Burkill S; Sveinsson O; Piehl F; Bahmanyar S; Remahl AIMN
All other publications
- Conference publication: CEPHALALGIA. 2025;45:118Deborgies C; Olofsgard FJ; Sundholm A; Lantz M; Sjostrand C; Waldenlind E; Steinberg A; Ran C; Belin AC
- Conference publication: CEPHALALGIA. 2025;45:236-237Lloyd J; Ran C; Wellfelt K; Steinberg A; Sundholm A; Carmine-Belin A
- Conference publication: JOURNAL OF HEADACHE AND PAIN. 2025;26(2)Sanches CD; Fourier C; Olofsgard FJ; Steinberg A; Sundholm A; Lantz M; Sjostrand C; Waldenlind E; Ran C; Belin AC
- Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024;33:435Fuglsang CH; Kousholt A; Bjork M-H; Sundholm A; Linder M; Reutfors J; Hoti F; Sveide I; Sorensen HT; Leon SL; Ehrenstein V
- Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2023;32:451Reutfors J; Leon SL; Kousholt A; Linder M; Bjork M-HH; Sundholm A; Hoti F; Bach FW; Ehrenstein V
- Letter: JOURNAL OF NEURO-OPHTHALMOLOGY. 2021;41(2):e272-e273Plant GT; Wong SH; Sundholm A; Mollan SP
- Doctoral thesis: 2020Sundholm A
- Conference publication: CEPHALALGIA. 2019;39:332Ackelman BH; Sundholm A; Kierkegaard M; Hedborg K; Waldenlind E; Ingela A; Remahl MN
- Conference publication: CEPHALALGIA. 2019;39:13-14Sundholm A; Burkill S; Waldenlind E; Bahmanyar S; Ingela A; Remahl MN
- Conference publication: CEPHALALGIA. 2019;39:299Sundholm A; Burkill S; Waldenlind E; Bahmanyar S; Ingela A; Remahl MN
- Conference publication: CEPHALALGIA. 2019;39:105-106Edvinsson M-L; Sundholm A; Steinberg A; Edvinsson L
- Review: LAKARTIDNINGEN. 2019;116:FI3RSundholm A; Träisk F; Hellgren K; Lundvall M; Söderman M; Gustavsson B; Nilsson Remahl I
- Conference publication: CEPHALALGIA. 2017;37:284Sundholm A; Burkill S; Bahmanyar S; Remahl IN
- Conference publication: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2016;25:99-100Sundholm AS; Burkill S; Sveinsson O; Bahmanyar S; Remahl IN
- Conference publication: CEPHALALGIA. 2015;35:111Sundholm A; Bahmanyar S; Sveinsson O; Piehl F; Remahl IN
Grants
- Hospital@Home: Person-centered Digital Transformation for Integrated Home Care. Work-package 6 Migraine Care (Karolinska is lead) and WP 7 Cluster Headache Care.Innovative Health Initiative Joint Undertaking (delegated by the European Commission)1 January 2026 - 30 June 2029A large collaborate research project to address emerging healthcare challenges through innovation, cross-sector cooperation, and the integration of technological solutions. The Hospital@Home (H@H) initiative aims to break the singular silo approach by focusing on multiple conditions that represent high morbidity, often require intensive monitoring and coordinated care. The chosen use cases include cardiovascular, pulmonology, minor stroke/TIA, migraine, and cluster headache, as these use cases show large promise for improving prevention through early detection of disease progression or degeneration by using advanced monitoring tools. The total funding for H@H was 21,8 million Euro.
- Migrän och behandling med botulinumtoxin; ger färre injektioner jämförbar effekt?Swedish Research Council1 January 2026 - 31 December 2026
- Planering av en randomiserad, placebokontrollerad, dubbelblind studie av lamotrigin för förebyggande behandling av migränauraSwedish Research Council1 January 2026 - 31 December 2026
Employments
- Senior consultant and Head of Section, Neurology, Department of Neurology, Karolinska University Hospital, 2006-
- Affiliated to Research, Department of Neuroscience, Karolinska Institutet, 2024-2026
Degrees and Education
- Degree Of Doctor Of Philosophy, Department of Clinical Neuroscience, Karolinska Institutet, 2020